IGF1 and neoplasm: The expert panel concluded that to achieve better disease control, there is a need for systematic evaluation of disease activity based on multiple parameters, including the use of defined tools such as the Acromegaly Disease Activity Tool (ACRODAT®), which includes IGF-I level, tumor status, symptoms, comorbidities, and quality of life (60).